T
TEM
TEM5 segments tracked|1 years of data|Annual (10-K)
Total Revenue
$1.3B0.0%
FY2024
Operating Segments
5Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Genomic
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Genomic | $452M | $0 | 0.0% | 33.9% | +0.0% |
| Clinical Order | $409M | $0 | 0.0% | 30.7% | +0.0% |
| Data And Services | $242M | $0 | 0.0% | 18.1% | +0.0% |
| Insights Product | $187M | $0 | 0.0% | 14.0% | +0.0% |
| Trials Product | $42M | $0 | 0.0% | 3.2% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free